跳至主要内容
临床试验/NCT04036825
NCT04036825Unknown不适用

Effectivity of Liquid Nutritional Supplementation in Improving Nutritional Status of Hospitalized Malnutrition Patients: A Single-Blind Randomized Controlled Trial

Fakultas Kedokteran Universitas Indonesia2 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2019年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
138
试验地点
2
主要终点
Change of Body Mass Index (BMI)

研究概览

简要总结

The aim of this study is to know the effectivity of liquid nutritional supplementation in malnutrition hospitalized patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • aged ≥ 18 years old to 60 years old
  • malnutrition hospitalized patient based on European Society for Clinical Nutrition and Metabolism (ESPEN) 2015 criteria
  • agreed to participate

排除标准

  • malignancy
  • chronic kidney disease stage III-V
  • decompensated hepatic cirrhosis
  • allergic to milk or lactose intolerance
  • could not be randomised and participate in this study by clinical judgement

研究组 & 干预措施

Liquid Nutritional Supplement from Hospital Product

Experimental

This group received liquid nutritional supplement from hospital product. The product is in a form of low lactose milk ready to drink with volume 200 ml and will be given 2 times daily for 14 days. This product is consist of 1.017 kcal/ml, 10 vitamin and 9 mineral

干预措施: Liquid Nutritional Supplement from Hospital Product (Dietary Supplement)

Placebo

Placebo Comparator

This group received standard liquid nutritional supplement as a placebo. Placebo will be given 2 times daily for 14 days

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Change of Body Mass Index (BMI)

时间窗: 0 and 14 days

BMI was assessed from height and body calculation. Classification of BMI is based on World Health Organization (WHO) classification.

次要结局

  • Change of Subjective Global Assessment (SGA) rank(0 and 14 days)
  • Change of body fat percentage(0 and 14 days)
  • Change of handgrip strength test score(0 and 14 days)
  • Change of lipid profile level(0 and 14 days)
  • Change of hemoglobin level(0 and 14 days)
  • Change of prealbumin level(0 and 14 days)
  • Change of blood glucose level(0 and 14 days)
  • Change of Blood Urea Nitrogen (BUN) level(0 and 14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marcellus Simadibrata, Prof. PhD., SpPD, KGEH

Prof. dr. Marcellus Simadibrata, Ph.D., SpPD-KGEH

Fakultas Kedokteran Universitas Indonesia

研究点 (2)

Loading locations...

相似试验